У нас вы можете посмотреть бесплатно Can We Really Extend Healthspan? Only If You're Rich или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Keywords Aging, longevity, healthcare, policy, lifespan, biotechnology, healthspan, societal change, aging research, advocacy Our latest discussion explores the universal desire for a healthy, long life, emphasizing that aging is a primary driver of disease. We consider various approaches to healthy ageing and the pursuit of a longer healthspan. While true solutions for how to live longer currently favor the wealthy, understanding aging biology and metabolic health are crucial for disease prevention. This episode prompts us to rethink access to longevity solutions for everyone. In this conversation, Kaushik Trivedi and Dylan Livingston explore the implications of aging as a treatable condition rather than an inevitable decline. They discuss the role of policy in shaping longevity research, the need for societal acceptance of aging interventions, and the potential economic benefits of extending healthy lifespans. The conversation also touches on the risks associated with longevity breakthroughs and the importance of making these advancements accessible to all. Ultimately, they emphasize the need for a shift in healthcare from reactive to proactive measures, highlighting the societal changes that could arise from longer, healthier lives. Chapters 00:00 The Uncomfortable Truth About Aging 01:26 The Disruption of Aging Policy 03:11 Dylan's Journey into Longevity Advocacy 08:44 Bridging Science and Policy 10:24 The Need for Diverse Voices in Longevity 12:12 Inspiration from Pioneers in the Field 13:04 The Unconventional Path to Advocacy 15:16 Curiosity Over Skepticism in Policy Discussions 19:18 Bipartisan Support for Longevity Initiatives 24:34 Aging 1.0 vs. Aging 2.0 27:07 The Economic Impact of Healthy Aging 30:11 Making Longevity Accessible to All 32:41 The Role of Government in Longevity Drug Accessibility 34:08 Awareness and Misconceptions in Longevity 36:51 Realism vs. Hype in Longevity Innovations 39:25 Mainstreaming Longevity Medicine 43:42 Government's Role in Longevity Interventions 47:35 Societal Changes with Extended Lifespan 53:09 The Future of Work and Leisure in an AI-Driven World 54:07 Potential Risks of Extended Lifespan 56:21 Hope and Challenges in Longevity Advocacy